Disease-Modifying Therapy for Transthyretin Amyloidosis

Disease-Modifying Therapy for Transthyretin Amyloidosis

Bibliographic Details
Main Author:	Nowell M. Fine, MD, SM
Format:	Article
Language:	English
Published:	Elsevier 2020-11-01
Series:	JACC: Case Reports
Subjects:	cardiomyopathy disease-modifying therapy transthyretin amyloidosis
Online Access:	http://www.sciencedirect.com/science/article/pii/S266608492031202X

Similar Items

Hereditary transthyretin amyloidosis: a case report
by: Angela Lee, et al.
Published: (2022-06-01)

Diagnostic algorithm in transthyretin amyloidosis with cardiomyopathy
by: Mariana Gospodinova, et al.
Published: (2020-07-01)

Prevalence, incidence and clinical outcomes of epicardial coronary artery disease among transthyretin amyloidosis cardiomyopathy patients
by: Rana Hassan, et al.
Published: (2023-03-01)

Diagnosis and Screening of Patients with Hereditary Transthyretin Amyloidosis (hATTR): Current Strategies and Guidelines
by: Benson MD, et al.
Published: (2020-08-01)

Specific Therapy for Transthyretin Cardiac Amyloidosis: A Systematic Literature Review and Evidence‐Based Recommendations
by: Nuno Marques, et al.
Published: (2020-10-01)

Transthyretin cardiac amyloidosis: an under-diagnosed cause of heart failure
by: Gabriela Molina O, et al.
Published: (2014-11-01)

Clinical and Genotype Characteristics and Symptom Migration in Patients With Mixed Phenotype Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey
by: Juan González-Moreno, et al.
Published: (2023-12-01)

Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year update
by: Angela Dispenzieri, et al.
Published: (2022-06-01)

Clinical characteristics in patients with hereditary amyloidosis with Glu54Gln transthyretin identified in the Romanian population
by: Andreea Jercan, et al.
Published: (2020-01-01)

Transthyretin amyloid cardiomyopathy: Treatment pipeline, clinical trials, and challenges
by: Sweety Sharma, et al.
Published: (2021-01-01)

Assessment and Management of Older Patients With Transthyretin Amyloidosis Cardiomyopathy: Geriatric Cardiology, Frailty Assessment and Beyond
by: Biobelemoye Irabor, et al.
Published: (2022-05-01)

A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS)
by: Luca Gentile, et al.
Published: (2023-11-01)

Oral Therapy for the Treatment of Transthyretin-Related Amyloid Cardiomyopathy
by: Mario Nuvolone, et al.
Published: (2022-12-01)

Modulation of the Mechanisms Driving Transthyretin Amyloidosis
by: Filipa Bezerra, et al.
Published: (2020-12-01)

Healthcare resource use associated with the diagnosis of transthyretin amyloidosis cardiomyopathy
by: Clint Asher, et al.
Published: (2022-01-01)

A clinical case of hereditary transthyretin amyloidosis. Case report
by: Anastasia A. Shoshina, et al.
Published: (2023-05-01)

Transthyretin cardiac amyloidosis: an update on diagnosis and treatment
by: Hiroyuki Yamamoto, et al.
Published: (2019-12-01)

Guideline of transthyretin-related hereditary amyloidosis for clinicians
by: Ando Yukio, et al.
Published: (2013-02-01)

Transthyretin Amyloidosis Therapies: Guiding the Future
by: Alejandra González-Duarte
Published: (2021-01-01)

Early-Onset of Transthyretin Amyloidosis in a Young Afro-Caribbean Woman With Thr60Ala Mutation
by: Stormy C. Keppel, MD, et al.
Published: (2020-11-01)

Clinical features and predictors of atrial fibrillation in patients with light‐chain or transthyretin cardiac amyloidosis
by: Maria Papathanasiou, et al.
Published: (2022-06-01)

Ligand conjugated antisense oligonucleotide for the treatment of transthyretin amyloidosis: preclinical and phase 1 data
by: Nicholas J. Viney, et al.
Published: (2021-02-01)

Wild-Type Transthyretin Cardiac Amyloidosis in a Transplanted Heart
by: Lily K. Stern, MD, et al.
Published: (2023-08-01)

Hereditary transthyretin-related amyloidosis is frequent in polyneuropathy and cardiomyopathy of no obvious aetiology
by: Volha Skrahina, et al.
Published: (2021-01-01)

New simple and quick method to analyze serum variant transthyretins: direct MALDI method for the screening of hereditary transthyretin amyloidosis
by: Toshiya Nomura, et al.
Published: (2019-05-01)

Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
by: Faruk Uğur Doğan, et al.
Published: (2019-03-01)

EGCG-Mediated Protection of Transthyretin Amyloidosis by Stabilizing Transthyretin Tetramers and Disrupting Transthyretin Aggregates
by: Huizhen Zou, et al.
Published: (2023-09-01)

Hereditary systemic transthyretin amyloidosis: a clinical case and an opinion on the problem
by: A. S. Draganova, et al.
Published: (2019-07-01)

Extracellular Vesicles Contribute to the Metabolism of Transthyretin Amyloid in Hereditary Transthyretin Amyloidosis
by: Hiroki Yamaguchi, et al.
Published: (2022-03-01)

SGLT2 inhibitor therapy for transthyretin amyloid cardiomyopathy: early tolerance and clinical response to dapagliflozin
by: Stephan Dobner, et al.
Published: (2023-02-01)

Clinical phenotypes and genetic features of hereditary transthyretin amyloidosis patients in China
by: Xinyue He, et al.
Published: (2022-09-01)

Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report
by: Hiroyuki Yamamoto, et al.
Published: (2018-12-01)

Coexistence of Light Chain and Transthyretin Cardiac Amyloidosis
by: Abhishek Gami, MD, et al.
Published: (2024-04-01)

Transthyretin Gene Variants and Associated Phenotypes in Danish Patients with Amyloid Cardiomyopathy
by: Torsten B. Rasmussen, et al.
Published: (2022-01-01)

Lack of Association Between Neurohormonal Blockade and Survival in Transthyretin Cardiac Amyloidosis
by: Richard K. Cheng, et al.
Published: (2021-12-01)

Urinary Transthyretin as a Biomarker in ATTRv Val50Met Amyloidosis
by: Hiroaki Matsushita, et al.
Published: (2022-06-01)

Diuretic Dose and NYHA Functional Class Are Independent Predictors of Mortality in Patients With Transthyretin Cardiac Amyloidosis
by: Richard K. Cheng, MD, MSc, et al.
Published: (2020-09-01)

The Transthyretin/Oleuropein Aglycone Complex: A New Tool against TTR Amyloidosis
by: Francesco Bemporad, et al.
Published: (2022-02-01)

Transthyretin cardiac amyloidosis in aortic stenosis: Prevalence, diagnostic challenges, and clinical implications
by: Giedre Balciunaite, et al.
Published: (2020-03-01)

Targeted sequencing of selected functional genes in patients with wild-type transthyretin amyloidosis
by: Inmaculada Moreno-Gázquez, et al.
Published: (2023-10-01)